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ABSTRACT. Hyperglycemic hyperinsulinemia cannot stim-
ulate intestinal protein synthesis in healthy individuals but
does so in conditions characterized by an altered somato-
tropic axis such as diabetes. Only in a state of growth hor-
mone resistance (high growth hormone but low insulin like
growth factor [IGF-1] concentrations), extra insulin may
acutely reverse the impaired, growth-hormone-induced
IGF-1 release, thereby exerting anabolic actions at the intes-
tinal tract. Growth hormone resistance can be also found in
patients after surgical stress. Therefore, we wanted to test
the hypothesis whether hyperglycemic hyperinsulinemia
would stimulate ileal protein synthesis in the latter condi-
tion. Mass spectrometry techniques (capillary gas
chromatography/combustion isotope ratio mass spectrome-
try) were used to directly determine the incorporation rate of
1-[13C]-leucine into ileal mucosal protein. All subjects had an
ileostomy, which allowed easy access to the ileal mucosa, and
consecutive sampling from the same tissue was performed
during continuous isotope infusion (0.16 mol/kg min). Iso-
topic enrichments and fractional protein synthesis were
determined at baseline (period I) and after a 4-hour glucose
infusion (170 mg/kg/h) or after infusion of saline (control
group) (period II). In controls, ileal protein synthesis declined
significantly during prolonged isotope infusion (period I:
1.11  0.14%/h, period II: 0.39  0.13%/h, p  .01). In
contrast, ileal protein synthesis remained constant during
glucose infusion (period I: 1.32  0.35%/h, period II: 1.33 
0.21%/h, n.s. vs period I, but p  .005 vs the corresponding
value at the end of period II in the control group). Using the
continuous tracer infusion technique, ileal protein synthesis
seemingly declines over a short time in control subjects. We
found evidence that this artificial decline was due to mass
effects of a rapidly turning over mucosa protein pool in which
an isotopic plateau was reached during the experiment and of
which the size amounted to approximately 4% of the total
mixed protein pool. Maintenance of ileal protein synthesis
during glucose infusion therefore indicates a rise of ileal
protein synthesis in a slowly turning over protein pool. This
effect in postsurgical patients would be compatible with the
concept of intestinal insulin action to depend on the specific
clinical state (eg, growth hormone resistance). ( Journal of
Parenteral and Enteral Nutrition 30:97–107, 2006)
Various substrates participate in regulating small-
intestinal protein mass and function. Luminal carbo-
hydrates may be of particular importance because of
their trophic action, thereby stimulating mucosal
growth, increasing mucosal mass, and maintaining
mucosal function.1,2 However, there is little evidence
that such effects can also be obtained by parenteral
glucose supply. Thus, in healthy subjects glucose in-
fusion did not alter duodenal protein synthesis3 or
splanchnic amino acid balances.4 Correspondingly,
various degrees of hyperinsulinemia remained without
anabolic effects in the splanchnic bed.5–7 Stimulatory
effects on splanchnic protein synthesis were also
absent when the insulin-induced hypoaminoacidemia
was prevented by simultaneous amino acid infusion.7
Experiments in adult dogs or pigs in which intestinal
protein metabolism could be evaluated selectively con-
firmed the absent anabolic actions of hyperglycemic8 or
euglycemic hyperinsulinemia9–12 at the gut.
These findings in healthy individuals are in contrast
to a recent study in patients with insulin-dependent
diabetes mellitus (IDDM) where even small amounts of
insulin increased duodenal protein synthesis in situ
significantly.13 Furthermore, carbohydrate-based par-
enteral nutrition in adult colitis patients could largely
maintain intestinal morphology and enterocyte pro-
liferation.14–17 The potentially different intestinal
insulin action in healthy and diseased subjects may be
explained by a varying release of secondary insulin-
induced mediators important for trophic effects at the
intestinal tract. One of those potent mediators is
IGF-1, which is known to stimulate mucosal growth
and enterocyte proliferation.18,19 Hyperinsulinemia/
hyperglycemia cannot raise concentrations of free dis-
sociable IGF-1 in healthy individuals20–23 but does so
in all conditions known to be associated with a high
baseline concentration of growth hormone and low
level of IGF-1 (growth hormone resistance). Thus, insu-
lin-mediated IGF-1 release has been observed in hypo-
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glycemia,22 diabetes,24 or malnutrition.25 Growth hor-
mone resistance is also present after surgical injury,26
and, correspondingly, also in such conditions insulin
has been found to accelerate IGF-1 release significant-
ly.20,27 Therefore, we wanted to test the hypothesis
whether a hyperglycemic hyperinsulinemia would
stimulate intestinal protein synthesis in patients dur-
ing postsurgical stress. To create a scenario that is
comparable to clinical routine, we used a carbohydrate
infusion to establish the desired degree of hyperinsu-
linemia. The carbohydrate infusion rate was set in a
way to produce insulin concentrations low enough not
to interfere with intestinal amino acid supply.7,9
A further aspect of the present study was to provide
an explanation for the rapid, unphysiologic decline of
mucosal tracer incorporation and protein synthesis
found recently in nonmalignant28 and malignant29
intestinal mucosa in situ when patients were studied




Two groups of postoperative patients (control, n  7;
carbohydrate infusion, n  6) with cured rectal carci-
noma and ileostomies were carefully screened through
medical history, physical examinations, and routine
blood tests. The groups were comparable with respect
to age (control: 60.3  3.1 year; carbohydrate infusion:
61.5  4.8) and body mass index (control: 23.4  0.7
kg/cm2; carbohydrate infusion: 24.4  0.9). Data of the
control group have been presented previously.28
Patients had limited colorectal cancer and had under-
gone curative, elective abdominal surgery, which had
also included construction of an ileostomy. All patients
had a preoperative bowel preparation (orthograde
flushing by oral colonoscopy fluids) and received pro-
phylactic IV antibiotics at the time of surgery. Anes-
thesia consisted of epidural application of analgesic
and anesthetic drugs, and was continued no longer
than the fifth postoperative day. The patients were
studied between days 8 and 10 after surgery, when
body protein loss peaks,29 had an uneventful postoper-
ative course, and were free from signs of organ mal-
function and local or systemic infection. Prior to sur-
gery, no patient had a history of previous weight loss or
clinical signs of malnutrition or metabolic diseases.
Informed consent was obtained after the experimental
protocol had been explained in detail. The study was
approved by the local institutional review board (pro-
tocol # 134/97).
Experimental Protocol
All subjects were inpatients of the general surgical
service. After surgery, patients received a mixed diet
(approximately 25 kcal/kg/d of which 5 kcal/kg/d were
administered as protein and free amino acids); one-
third of the calories was administered enterally (liq-
uids) and the other two-thirds parenterally. After 10
PM, all subjects remained postabsorptive, except for
consumption of mineral water, and parenteral nutri-
tion was discontinued. A primed-constant infusion of
1-[13C]-leucine (Tracer Technologies, Sommerville,
MA; 99.3 atom % enrichment) was started at 7 AM the
next day. The isotope infusion rate was 0.16 mol/kg
min (prime 9.6 mol/kg). A blood sample was collected
before isotope infusion to determine the background
enrichment of protein-bound and free plasma leucine.
Plasma background enrichments were used as an indi-
cator of intracellular protein-bound and free leucine
background enrichments.30
The first mucosal biopsy was performed after 180
minutes of isotope infusion, the second after 360 min-
utes, and the third after 600 minutes. The baseline
period (period I) ranged from 180 to 360 minutes.
Between minutes 360 and 600 (after the second biopsy,
period II), patients in the carbohydrate group received
a continuous glucose infusion (170 mg/kg h). Patients
in the control group remained in a fasting state.
Assignment to the control or carbohydrate group was
done by random order. Arterialized blood samples for
measurement of glucose and insulin concentrations
were taken at the same time as mucosal biopsies. The
minimum distance between biopsy sites was 2 cm. The
average biopsy size was 10 mg wet weight.
Procedures
Study methods and data analysis were discussed in
detail previously.30 The free and protein-bound amino
acids in tissue biopsies were separated by protein pre-
cipitation. After protein hydrolysis, amino acids were
separated from the accompanying impurities by cation-
exchange chromatography. For capillary gas chroma-
tography and combustion isotope ratio mass spectrom-
etry analysis, amino acids from proteins (on average
7–8 ng) were then converted to the N-acetyl n-propyl
ester. For gas chromatography and quadrupole mass
spectrometry analysis, we prepared the tert-butyldi-
methylsilyl derivative from free intracellular amino
acids. N-acetyl n-propyl-amino acid derivatives were
analyzed in a capillary gas chromatography and com-
bustion isotope ratio mass spectrometry system that
consisted of a Hewlett-Packard 5890 Series II gas chro-
matograph interfaced to a mass spectrometer Delta S
(Finnigan MAT, Bremen, Germany). Tert-butyldi-
methylsilyl derivatives were analyzed by a gas chro-
matography and quadrupole mass spectrometry sys-
tem (MSD 5971D, Hewlett-Packard, Houston, TX).
Isotopomere ratios of the sample were obtained by
electron impact ionization and selected ion monitoring
at mass-to-charge ratios 303 and 302. Data were
expressed as tracer/tracee ratios.
Plasma glucose concentration was determined enzy-
matically, and insulin concentrations were measured
via immunoassay.
Calculations
The tissue fractional synthetic rate in the metabolic
steady state was calculated by dividing the increment
in protein-bound 1-[13C]-leucine tracer/tracee ratio by
enrichment of the precursor pool.30 As a substitute for
the true precursor pool enrichment (tRNA-bound
amino acid enrichment), we used the free homogenate
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1-[13C]-leucine tracer/tracee ratio.28 Delta increments
of protein-bound 1-[13C]-leucine enrichment between
biopsy samples were calculated from isotope ratios
[13C]/[12C] using a correction factor that takes into
account dilution of the label at the carboxyl position by
the other carbon atoms in the derivatized leucine.30
The fractional synthetic rate (FSR) was then calcu-
lated as follows:
FSR 
RL (ti1)  RL(ti)




 60  100 (%/h). (1)
RL(ti) and RL (ti  1) correspond to the tracer/tracee
ratio of ileal protein-bound leucine in 2 subsequent
samples (i and i  1), separated by the time interval t
(min). RL(ti) and RL(ti1) indicate the tracer/tracee
ratios of ileum-free leucine in 2 subsequent samples.
Average values between RL(ti) and RL(ti  1) were
used as precursor enrichments for ileal protein synthe-
sis. The factors 60 (min) and 100 are needed to express
the fractional synthetic rate in percentage per hour.
Patients in the carbohydrate group demonstrated a
significant increase in the precursor pool enrichment
during the 10-hour isotope infusion (Table I), possibly
indicating a non–steady-state situation. In this case,
an equation different from equation 1 would have to be
used to calculate FSR.31 This equation requires knowl-
edge of tracer and tracee concentrations in the free
amino acid and protein pool, which are, however, dif-
ficult to obtain from biopsies of ileal mucosa in situ. As
an alternative, equation 1 can still be used, if piecewise
constant functions between pairs of consecutive sam-
pling points can be identified.31 Because the free tissue
homogenate leucine enrichment did not differ signifi-
cantly between samples taken at 180 and 360 minutes
and 360 and 600 minutes, respectively, one may
assume a steady-state-like condition between sampling
points 1 and 2 and 2 and 3, justifying use of equation 1
to calculate FSR separately for those 2 study intervals.
To analyze the speed of tracer incorporation sepa-
rately in periods I and II, we calculated the absolute
increase of the protein-bound tracer/tracee ratio per
hour during the 10-hour isotope infusion by the for-
mula:
 RL/h  [{RL (ti  1)  RL(ti)}/t]  60 (2)
Tracer incorporation during the study is measured in
a mixed protein sample but is known to occur in dif-
ferent protein pools with different turnover. Isotopic
enrichments in these protein pools may reach an iso-
topic plateau before the first sample is taken (very
rapidly turning over protein pool), between the first
and the last sample (rapidly turning over protein pool),
or after the last sample (slowly turning over protein
pool). For such protein pools with different turnover,
several boundary conditions may be derived from the
data measured in the control group (with stable exper-
imental conditions). The theory behind this multiple
pool hypothesis and deduction of corresponding bound-
ary conditions are presented in the Appendix. These
boundary conditions must be compatible with each
other if the pool concept is correct. If so, individual pool
sizes may eventually be estimated.
Statistics
Data are expressed as mean  SEM. Protein syn-
thetic rates from control patients and patients in the
carbohydrate group (6-hour isotope infusion) were com-
pared by the unpaired t test. The paired t test was used
to compare protein synthetic rates and the speed of
tracer incorporation within each group between peri-
ods I and II. ANOVA (analysis of variance) was used to
compare the free homogenate leucine tracer/tracee
ratios between the 2 groups and between the 3 differ-
ent sampling points. A p value of .05 or less was taken
as indicating a significant difference.
RESULTS
Plasma glucose and insulin concentrations rose sig-
nificantly during carbohydrate infusion (glucose, end of
period II: 165.0  5.9 mg/dL, p  .05 vs 111.5  4.5 at
the end of period I; insulin, end of period II 25.1  4.3
Ul/mL, p  .05 vs 9.4  1.4 U/mL at the end of
period I), whereas glucose and insulin concentrations
remained unchanged in control patients (glucose, end
of period II: 96.3  2.0 mg/dL, n.s. vs 103.5  3.8 at the
end of period I; insulin, end of period II 7.2  1.1
Ul/mL, n.s. vs 6.3  0.6 U/mL at the end of period I),
resulting in a significant difference of insulin and glu-
cose concentrations between controls and subjects
receiving glucose at the end of period II (p  .05).
Analysis of tracer data showed that only in the con-
trol group did the tracer/tracee ratio in the mucosa-free
homogenate leucine pool ( precursor pool for protein
synthesis) not change significantly over time (Table I).
In patients receiving carbohydrates, the precursor pool
enrichment rose significantly over time. Thus, the
enrichment in sample 3 (600 minutes of isotope infu-
sion) was significantly higher than the corresponding
enrichment in sample 1 (180 minutes of isotope infu-
sion).
Table II and Figure 1 show the values of protein-
bound leucine enrichment and the time curve of tracer
incorporation into ileal mucosa over time. In both
groups, tracer incorporation was not linear. On aver-
age, in patients receiving carbohydrates the
tracer/tracee ratio rose at 0.0056  0.004% per hour in
period I (hours 3–6) and at 0.083  0.004% per h in
period II (hours 6–10, period of glucose infusion, p 
.05). In contrast, incorporation slowed down signifi-
cantly over time in control patients (0.057  0.005%
TABLE I
Tracer/tracee ratios of 1-	13C
-leucine in free intracellular leucine of ileal







Control 5.24  0.46 5.37  0.47 5.46  0.35
Glucose infusion 5.01  0.89 6.15  1.14 6.48  1.28†
*Values are given as % (mean  SEM). Sample 1 was taken after 180
minutes, sample 2 after 360 minutes, and sample 3 after 600 min-
utes of isotope infusion. Patients in the glucose infusion group
received 170 mg/kg/h glucose between 360 and 600 minutes. Control
patients continued to fast throughout the study.
†p  .05 vs sample 1.
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per h in period I, 0.019  0.005% per h in period II, p 
.001). The speed of tracer incorporation in period II
differed also significantly between groups (p  .05).
During carbohydrate infusion fractional protein syn-
thesis remained stable. Thus, ileal protein synthesis
amounted to 1.32  0.35%/h in period I and to 1.33 
0.21 in period II (n.s.). In contrast, ileal fractional
protein synthesis in control patients declined signifi-
cantly over time (period I: 1.11  0.14%/h, period II:
0.39  0.13%/h, p  .05 vs period I and vs the corre-
sponding value at the end of period II in the carbohy-
drate group; Figure 2).
As outlined in the Appendix, the rapid decline of
tracer incorporation and mucosa protein synthesis over
time in controls does not represent a true change of
tissue protein synthesis but results from mass effects
of a rapidly turning over protein pool in which an
isotopic plateau is reached during the experiment. For
such a rapidly turning over mucosa protein pool, sev-
eral different boundary conditions can be derived from
the data measured in the control group (with stable
experimental conditions). As can be seen in the Appen-
dix section, none of the boundary conditions conflicts
with any other, and the size of the rapidly turning over
protein pool can be estimated, approximately amount-
ing to 4% of the total protein pool in the sample.
DISCUSSION
This study shows that after major abdominal sur-
gery, a mild hyperglycemia/hyperinsulinemia stimu-
lates protein synthesis in ileal mucosa significantly.
Thus, after a 4-hour infusion of 2.8 mg/kg/min glucose,
ileal fractional protein synthetic rate was 300%
higher than the corresponding rate in control patients
(Figure 2).
To interpret the carbohydrate effect correctly, it is
essential to analyze the changes of ileal protein syn-
thesis over time in the control group. Thus, during a
10-hour tracer infusion in postabsorptive patients, we
observed a rapid, marked decline of protein synthesis,
falling significantly from about 1.11%/h–0.39%/h. As
can be seen in Figure 1, tracer incorporation into muco-
sal protein in fasting postoperative patients (control
group) was not linear over time but slowed down
between the sixth and 10th hour of isotope infusion,
resulting in a rapid decrease of small-bowel protein
synthesis during this time. Similar observations have
been made in rat liver32–34 when tracers were given
continuously over prolonged periods of time. It can be
concluded that this rapid marked decrease resulted
from the effect of fasting because, by use of published
sources,35,36 one can calculate that human small-bowel
protein synthesis declines by only 1.3%/h during a
36-hour fasting period.
TABLE II








1 0.20 0.33 0.63
2 0.15 0.35 0.54
3 0.33 0.45 0.71
4 0.28 0.42 0.67
5 0.14 0.39 0.60
6 0.23 0.37 0.82
Control
1 0.15 0.36 0.54
2 0.04 0.21 0.27
3 0.16 0.33 0.30
4 0.15 0.34 0.42
5 0.06 0.25 0.28
6 0.17 0.34 0.44
7 0.23 0.30 0.35
*Values are given as %. Sample 1 was taken after 180 minutes,
sample 2 after 360 minutes, and sample 3 after 600 minutes of
isotope infusion. Patients in the glucose infusion group received 170
mg/kg/h glucose between 360 and 600 minutes. Control patients
continued to fast throughout the study.
FIGURE 1. Time curves of tracer incorporation into ileal mucosa in control patients and patients receiving carbohydrates during a 10-hour
isotope infusion. Patients in the glucose infusion group received 170 mg/kg h glucose between 360 and 600 minutes. Control patients
continued to fast throughout the study.
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For rat liver, this phenomenon has been explained by
different protein pools with different protein turnover
rates and corresponding different speeds of isotope
incorporation.32 The existence of such differing pools
has been shown in rodent and dog liver33,37 and in
rodent small intestine38 and intestinal brush border.39
To explain the decline in hepatic tracer enrichment
over time mathematically, one has to describe mixed
protein enrichments (as obtained from mucosal biop-
sies) as the sum of all enrichments measured at a
certain point of time in all the various protein pools in
a tissue.
It is obvious that turnover of individual proteins
varies between a few minutes and many days.37,40,41
Therefore, the time will also vary after which all pro-
teins in a specific pool will be labeled during a contin-
uous tracer infusion and at which point the isotopic
plateau is being reached. Beyond that point, only those
individual proteins or protein pools will add to the
rising enrichment of the total pool that have not yet
reached their isotopic plateau. Because of mass effects
of the different pools, the speed of tracer incorporation
will be lower at this later period of tracer infusion,
resulting in seemingly reduced rates of protein synthe-
sis over time (see Appendix for details).
Assumption of a comparable plateau effect in intes-
tinal mucosa of our study would require gut proteins in
which the enrichment reaches its plateau not later
than 6 hours after the beginning of the isotope infu-
sion. Proteins of this type would belong to a rapidly
turning over protein pool. Rapidly turning over pro-
teins should have a fractional synthetic rate of at least
100%/6 hours, or about 17%/h. With protein mass and
turnover constant, this synthetic rate would corre-
spond to a protein half-life of approximately 3 hours. A
variety of enzymes or epithelial glycoproteins such as
lactosaminoglycans or proteoglycans were found to
have turnover rates in that range,42–45 and a signifi-
cant portion of cellular protein shows a half-life of 3.5
hours.46 Although half-lives of certain glycoproteins,
such as sucrase, lactase or disaccharidase, were found
to be somewhat higher in in vitro experiments (around
12 hours), these proteins are susceptible to turnover
acceleration by a various physiologic and pathophysi-
ologic stimuli, most likely resulting in a significantly
shorter in vivo half-life.42,46–51
For such a rapidly turning over protein pool, several
boundary conditions can be defined from the data mea-
sured in the control group (with stable experimental
conditions). These boundary conditions must be com-
patible with each other if the concept of a rapidly
turning over protein pool is correct. As can be seen in
the Appendix section, none of the 5 boundary condi-
tions conflicts with any other, thereby supporting the
hypothesis of a rapidly turning over pool effect. Fur-
thermore, we could calculate from our data an approx-
imate size of the rapidly turning over protein pool of
about 4% (of the total mixed pool).
This pool size estimation for those rapidly turning
over proteins in our study cannot be compared with
any human data. In rats, it was found that sucrase-
isomaltase and maltase account for approximately 1%
of mucosa proteins.52 Total glycoprotein synthesis was
found to be responsible for 6%–10% of total tracer
incorporation in the mucosa,53 whereas in rat liver
about 10% of all proteins show a rapid turnover in the
above range.37,41 Our calculation of a size of 4% for
such a rapidly turning over protein pool in human
postoperative ileal mucosa would be in the range of
these estimates and would, therefore, also support the
validity of the rapidly turning over pool concept for
explaining the enrichment changes that were seen dur-
ing continuous isotope infusion over prolonged periods
of time in ileal mucosa from controls.
FIGURE 2. Effect of carbohydrate infusion on ileal protein fractional synthetic rate (%/h, mean  SEM). Period I ranged from hour 3 to hour
6; period II, from hour 6 to hour 10. Patients in the carbohydrate group received a glucose infusion (170 mg/kg h) during period II. *p  .05
vs period I. §p  .05 vs control.
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Assumption of such a pool concept would also affect
the interpretation of experiments performed to alter
mucosal protein synthesis. In our studies, manipula-
tions started after the second sample (at 6 hours of
isotope infusion, after a baseline period). If a manipu-
lation would then stimulate only protein synthesis in
the rapidly turning over protein pool, it would be
missed because the plateau enrichment cannot sur-
mount the precursor pool enrichment in any case. On
the other hand, effects on protein synthetic rates in the
slowly turning over protein pool (which reaches its
isotopic plateau only after the 10th hour of tracer infu-
sion) will be detected because corresponding enrich-
ments in this pool will rise, whereas the plateau
enrichment in the rapidly turning over protein pools
will remain constant. Therefore, it is safe to conclude
that carbohydrate infusion must at least have stimu-
lated ileal protein synthesis in this slowly turning over
pool (Figure 3).
Principally, 2 mechanisms could have been respon-
sible for the stimulation of ileal protein synthesis dur-
ing glucose infusion. Thus, carbohydrate infusion did
not only lead to hyperinsulinemia but also increased
plasma glucose concentrations. However, changes in
glucose concentration per se are commonly believed not
to affect protein metabolism significantly, because
hyperglycemia in combination with constant insulin
concentrations was without effect on plasma leucine
concentration or appearance rate,54,55 or on intestinal
glucose uptake.56 Therefore, variations in insulin con-
centration are usually considered the main effectors of
changes in total body or muscle protein metabolism
observed during hyperinsulinemic hyperglycemia.57
However, in healthy postabsorptive individuals
these anabolic effects are apparently absent at the
intestinal tract. Thus, in dogs and humans, various
degrees of hyperinsulinemia did not change splanchnic
or gut amino acid balances significantly.5,9,10 Further-
more, when regional catheter techniques were com-
bined with amino acid tracer infusion, studies in
healthy subjects revealed that euglycemic hyperinsu-
linemia was associated even with a fall in splanchnic
protein synthesis (calculated without direct measure-
ment of tracer incorporation).6 In dogs in which gut
protein metabolism could be examined selectively,
euglycemic hyperinsulinemia was found to reduce
intestinal leucine use and production simultaneously,
thereby explaining the unchanged gut amino acid bal-
ances.10 The inhibitory effects of insulin on gut protein
synthesis and amino acid use are usually explained by
the simultaneous, insulin-mediated intestinal deficit
of amino acids.57 However, even with simultaneous
amino acid replacement, euglycemic hyperinsulinemia
did not stimulate splanchnic protein synthesis in
healthy subjects7 or gut protein synthesis in pigs.11,12
Therefore, it is surprising that a recent study in insu-
lin-dependent diabetic subjects13 found that only small
amounts of insulin increased duodenal mucosal protein
synthesis significantly (measured directly via tracer
incorporation) and that carbohydrate-based parenteral
nutrition prevented mucosal atrophy and dysfunction
in catabolic colitis patients.14–17 These observations
and our findings are in clear contrast to the results of
O’Keefe et al3 in healthy volunteers in whom hypergly-
cemic hyperinsulinemia did not alter duodenal protein
synthesis in situ.
FIGURE 3. Hypothetical tracer/tracee ratios in different mucosa protein pools during a 10-hour tracer infusion. Numbers for individual pools
were estimated as indicated in the Appendix section. An approximate size of the very rapidly turning over protein pool of 0.5% and of the
rapidly turning over protein pool of 3.8% was assumed.
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A possible explanation for those discrepant results
may be found in the accompanying circumstances and
mechanisms determining insulin action in health and
disease. Catabolic illnesses such as surgical stress,
malnutrition, but also NIDDM are all characterized by
a disturbed somatotropic axis.25,26,58 Associated patho-
logic changes are characterized by growth hormone
resistance due to reduced hepatic growth hormone
receptor expression. The latter results from portal
insulin deficiency in NIDDM, protein deficiency in mal-
nutrition, or increased cytokine release in inflamma-
tory or posttraumatic disorders.25,26,58 As a common
consequence shared by all these diseases, plasma con-
centrations of free and total IGF-1 decline causing a
secondary, compensatory rise in pituitary GH release.
When hepatic insulin availability rises acutely in such
a situation (either by stimulated endogenous release or
exogenous infusion), a strong permissive effect on
hepatic GH action can be observed. Due to its stimu-
latory action on hepatic GH receptor expression,59
insulin will acutely reverse the impaired hepatic GH
effects, thereby acutely increasing IGF-1 synthesis and
plasma concentration significantly. Corresponding
insulin effects on IGF-1 have been demonstrated in all
of the above diseases.20,24,25,27 This endocrine scenario
also explains why insulin-induced IGF-1 release does
not occur in healthy subjects where pituitary growth
hormone output and IGF-1 levels are normal, thereby
abolishing the permissive effect of insulin on hepatic
IGF-1 production.20–23 Considering the strong anabolic
effects of IGF-1 at the gut,18,19 the same scenario may
explain why hyperinsulinemia stimulates intestinal
protein synthesis in diseased but not in healthy sub-
jects.
CONCLUSIONS
In conclusion, our results clearly suggest that hyper-
glycemic hyperinsulinemia does have a profound effect
on human ileal protein metabolism after surgical
trauma. They may also explain how IV carbohydrates
can contribute to the maintenance of villous height and
enterocyte proliferation, and to the conservation of
mucosal protein, DNA and RNA content observed clin-
ically during parenteral nutrition in catabolic diseases,
despite the absence of a luminal substrate supply.14–17
Furthermore, our results demonstrate that at least at
the gastrointestinal tract, findings from healthy sub-
jects cannot necessarily be applied to diseased individ-
uals.
APPENDIX
Rationale of the 3-Pool Model
Turnover of individual proteins varies between a few
minutes and many days. When tracer is given contin-
uously, after a certain amount of time all existing
protein in an individual pool will have incorporated the
tracer. The amount of time required for this state to be
reached depends on the individual turnover rate and
can be used to calculate fractional protein synthesis
and half-life if turnover and mass remain constant.
Thus, after a linear phase with a continuous increase of
tracer enrichment, the enrichment in a particular pro-
tein will reach a plateau of which the magnitude cor-
responds to the magnitude of tracer enrichment in the
precursor pool. The enrichment measured at a certain
time in a mixed protein pool will, therefore, combine
enrichments of proteins in which the incorporation is
still rising and of those in which the enrichment is
already at plateau. The relative contribution of these
individual enrichments to the total enrichment will
depend on the time passed since the beginning of the
tracer infusion (Figure 3).
However, during a limited experiment (as ours with
a 10-hour duration) with several sampling points (3 in
our experiment), not all protein pools with different
turnover will affect the enrichment measured in a
mixed sample to the same degree. To account for this
phenomenon, a 3-pool model (Figure 3) has been intro-
duced by Koch.34 In the first pool, some proteins will
have a turnover slow enough that a plateau is not
being reached during an experiment (in our case, a
10-hour experiment). In these proteins, tracer incorpo-
ration will be linear and these proteins will add ade-
quately to the continuous rise of tracer enrichment in
the samples, although individual synthetic rates will
vary. Then, there will be other proteins (second pool),
of which turnover is so rapid that a plateau is already
reached before the first sample is taken (after 3 hours
of tracer infusion in our case). Irrespective of their
individual synthetic rate, these proteins will not add to
the rise of tracer enrichment observed in the remaining
proteins in all subsequent samples. Because protein
synthesis is calculated from the absolute difference
between enrichments in samples obtained at different
times, synthesis of proteins in this very rapidly turning
over protein pool cannot be measured by an experimen-
tal design as ours.
Finally, there will be other proteins (third pool) of
which the enrichment reaches a plateau during the
experiment (between the third and the 10th hour of
isotope infusion in our study). Samples taken before
that plateau is reached will still show a linear rise in
enrichment because tracer incorporation is still ongo-
ing in all proteins. Samples taken after some proteins
have reached a plateau will show disproportionately
lower enrichments in mixed protein samples, because
those proteins will no longer contribute to the enrich-
ment of the mixed sample. Thereby, a deceleration of
tracer incorporation will be observed in the mixed pro-
tein pool if 3 subsequent samples are compared with
each other and if the size if this third pool is of suffi-
cient magnitude. Calculation of fractional protein syn-
thesis will then yield a seeming fall of protein synthesis
over time.
This effect will be maximal if the percentage of these
plateauing proteins in the mixed sample is high and if
they reach their plateau between the first and the
second of 3 consecutive samples. Deceleration of tracer
incorporation will be lower if the plateau is reached
between the second and third sample. In that case,
enrichments in the proteins plateauing after the sec-
ond sample, and, therefore, in the proteins of the mixed
protein pool in the second sample, will be lower than
corresponding enrichments in that sample, which
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would have been measured if the enrichment in the
respective proteins had plateaued before the second
sample was taken. With a later plateau, the absolute
enrichment difference between the second and third
sample would rise, reducing the decelerating effect of
the plateau mechanism on tracer incorporation
between the second and third sample.
Boundary Conditions for the Mucosal 3-Pool Model and
Estimation of Pool Size in Control Subjects
A 3-pool model of protein turnover in intestinal
mucosa is being proposed. One pool (I) consists of rap-
idly synthesized proteins in which tracer incorporation
would reach a plateau during the tracer infusion (with
a maximum effect when the plateau is reached after 6
hours); this rapidly turning over protein pool should
have an estimated fractional synthetic rate of 15%–
20%/h and a half-life of 2–3 hours. Another pool with
slower turnover rates (II) would show a continuous
linear tracer incorporation during the whole experi-
ment (third to 10th hour). Proteins with an extremely
rapid turnover (reaching their isotopic plateau before
the third hour of tracer infusion) are part of still
another pool (III) with a fractional synthetic rate of
33%/h and a half-life of 1–1.5 hours or less.
Using the enrichments observed in the mixed
mucosa protein pool (Table II) and the constant pre-
cursor pool enrichment (Table I) of controls, and using
the above assumption on the specific qualities of the
different pools, it is possible to define boundary condi-
tions for the 3-pool model. These conditions must all be
compatible with each other if the multiple pool model is
correct. If so, they could also be used to estimate the
relative size (k) of the rapidly turning over protein pool
(I) in postoperative ileal mucosa.
In the following calculations, the variables for rela-
tive tracer and tracee amounts in different pools and
samples are defined as indicated in Table III.
Tracer/tracee values in the mixed protein pool rep-
resent mean values from actual measurements in post-
operative controls in samples obtained after 3, 6, and
10 hours of isotope infusion (as presented in Table II).
k and k indicate the amount of tracee in the rapidly
and very rapidly turning over protein pool (pool size) as
referred to an arbitrary amount of tracee of 1000 in the
mixed pool, which combines the 3 other pools. The
amount of tracee in the slowly turning over protein
pool is obtained by subtracting k and kfrom 1000. Ri,
ri, si, and mi indicate the amount of tracer in the very
rapid, rapid, slow, and mixed turnover pools after 3, 6,
and 10 hours of isotope infusion.
For a 3-pool model, the following boundary condi-
tions can be defined and possibly be used to estimate k:
1. If the rapidly turning over protein pool reaches its
plateau between the third and sixth hour of tracer
infusion, then
r6/k  r10/k or r6  r10 (1)
2. Between hours 0 and 6 of the tracer infusion,
enrichments in the rapidly turning over protein pool
should rise linearly up to a turning point from which
the plateau is being approached. During this tempo-
rary linear rise, the enrichment (rt/k) at a certain time
t that has passed since the beginning of the isotope
infusion will follow the equation:
rt/k  a  t  b (2)
At time t  0, the enrichment (tracer/tracee ratio)
should be also 0. Therefore, b equals 0, leaving
rt/k  a  t (3)
The magnitude of “a” equaling the slope of the linear
curve will depend on the exact time at which the turn-
ing point and the plateau enrichment, respectively, are
being reached. If the plateau is to be reached before or
at the sixth hour of tracer infusion, “a” will have to be
larger than the slope “ah” of a hypothetical, perma-
nently linear curve, which would rise uniformly and
without a turning point from time zero until the value
of the plateau enrichment is crossed exactly after 6
hours of tracer infusion. This hypothetical curve can be
described by the equation:
yt  ah  t (4)
t equals the time passed since the beginning of the
tracer infusion. Because at t  6 (after 6 hours of tracer
infusion), y6 should equal 0.055 (enrichment in the pool
of the free intracellular amino acids  plateau enrich-
ment of the rapidly turning over pool, Table I), ah will
then be 0.055/6  0.0092. From a  ah and from a 
rt/(kt), according to equation 3, follows rt/k 0.0092  t.
Thus, after 3 hours of isotope infusion, r3/k will have to
be larger than 0.0275 or
r3  0.0275  k (5)
3. Because the plateau enrichment in the rapidly and
very rapidly turning over protein pool corresponds to
the precursor pool enrichment (enrichment in the pool
of the free intracellular amino acids, Table I), it
amounts to approximately 5.5%, or 0.055 (average
value for all measurements in postsurgical control
patients). Therefore,
r6/k  r10/k  0.055, or r6  r10  0.055k (6a)
R3/k  R6/k 
R10/k  0.055, or R3  R6  R10  0.055k (6b)
4. The amount of tracer in the mixed pool must be
the sum of tracer in all other pools. Therefore,
R3  r3  s3  1.4 ( m3) (7)
R6  r6  s6  3.0 ( m6) (8)
R10  r10  s10  3.8 ( m10) (9)
Since r6  r10  constant,
the difference s10  s6 must equal m10  m6  0.8 (10)
(for the 4-hour tracer infusion between hours 6 and 10
of the experiment).
5. In contrast to the rapidly turning over pool,
enrichment in the slowly turning over pool should rise
linearly during tracer infusion. Therefore,
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s6  s3  (s10  s6)  3⁄4  (m10  m6)  3⁄4  0.6
(11)
The correction 3⁄4 is necessary because only 3 hours
elapse between the third and sixth sample, in contrast
to the 4 hours separating the 6-hour and 10-hour sam-
ples.
Eqs. 8–11 can be transformed to yield expressions
for the amounts of tracer in r and s, depending on k and
k:
s10  3.8  r10  R10  3.8  0.055 (k  k)
(12)
s6  3.0  r6  R6  3.0  0.055 (k  k) (13)
s3  s6  0.6  2.4  0.055 (k  k) (14)
r3  1.4  s3  0.055 (k  k)  1.0 (15)
Combination of eqs. 5 and 15 yields boundary condi-
tion #1 not depending on k:
k 36.4 (16)
Since all r and s must be 0, further boundary condi-
tions depending on k can be derived from eqs. 12–15.
Thus, k 69.1  k (#2, from eq. 12), k 54.6  k (#3,
from eq. 13), k 43.6  k (#4, from eq. 14), and k
18.2  k (#5, from eq. 15).
Combining conditions #1 with #4 yields an upper
estimate for k:
36.4  43.6  k, or k 7.2 (17)
Therefore, referred to a hypothetical pool size of tra-
cee in the mixed pool (1000), the size of the very rapidly
turning over protein pool (III) should not be 0.7% of
the total, mixed pool. This size would be compatible
with experimental findings. Thus, the fraction of this
labile protein pool with a very rapid turnover has been
estimated in the past in growing prokaryotic cells. k
was found to be about 10–20 (1%–2% of the total pro-
tein pool) but is significantly less in eukaryotic
cells.60,61
Assuming a maximum of k of 7 (corresponding to
0.7%), the following boundary conditions for kk7 can be
deduced from eqs. 12–15. Thus, kk7 52.1 (from eq.
12), kk7 47.6 (from eq. 13), kk7 36.6 (from eq. 14),
and kk7 11.2 (from eq. 15). Combining all these con-
dition with condition #1 yields:
36.4  kk7 36.6.
Assuming a hypothetical value of k  0 and using
again the above conditions, one obtains:
36.4  kk0 43.6.
It is evident that all corresponding boundary condi-
tions are compatible with each other, indicating that
the measured data in the control group would be com-
patible with the proposed pool model. Furthermore, it
can be deduced that, depending on the precise size of
k, k can lie between 36.4 and 43.6. Referred to a
hypothetical pool size of tracee in the mixed pool
(1000), the size of the rapidly turning over protein pool
may be about 4% of the total, mixed pool.
Assuming an approximate size of the very rapidly
turning over protein pool of 0.5% and of the rapidly
turning over protein pool of 3.8%, one may, for exam-
ple, calculate tracer/tracee ratios at all sampling points
for the slowly turning over protein pool and for the
3-hour sample of the rapidly turning over protein pool
(see Table III above). Considering the different plateau
effect of the rapidly and very rapidly turning over
protein pool, hypothetical graphs can be designed that
reflect the principal changes over time of tracer/tracee
ratios in the different pools (Figure 3).
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